Gerrit‐Jan Liefers

12.6k citations

243 papers · 9.0k indexed · 1 hit paper · h-index 52

Oncology top 0.2%
- Global Cancer Incidence and Screening 46
- Colorectal Cancer Surgical Treatments 32
- Colorectal Cancer Treatments and Studies 21
Cancer Research top 0.5%
- Breast Cancer Treatment Studies 95
Geriatrics and Gerontology top 0.5%
- Frailty in Older Adults 20
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 32
- Breast Lesions and Carcinomas 20
Pulmonary and Respiratory Medicine top 1%
Genetics
- Estrogen and related hormone effects 18

Co-authors: Cornelis J.�H. van de Velde Esther Bastiaannet Hein Putter Peter J.K. Kuppen Rob A.�E.�M. Tollenaar Vincent T.H.B.M. Smit Johanneke E.A. Portielje W. van de Water
Cited by: Oncology Cancer Research Geriatrics and Gerontology
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Gerrit‐Jan Liefers

232 papers receiving 8.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data

Peers

Countries citing papers authored by Gerrit‐Jan Liefers

Since Specialization

Citations

This map shows the geographic impact of Gerrit‐Jan Liefers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit‐Jan Liefers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit‐Jan Liefers more than expected).

Fields of papers citing papers by Gerrit‐Jan Liefers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit‐Jan Liefers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit‐Jan Liefers. The network helps show where Gerrit‐Jan Liefers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gerrit‐Jan Liefers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerrit‐Jan Liefers Line = papers co-authored together Gerrit‐Jan Liefers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index Marie-France Jilderda,Yi Zhang,Valerie Rebattu,Ranelle Salunga,Wilma E. Mesker,Jenna Wong,Linda de Munck,Tommy� Fornander,Bo Nordenskjöld,Olle Stål,Amanda Anderson,Esther Bastiaannet,Kai Treuner,Gerrit‐Jan Liefers	2025	1
2	Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFNα Els M.E. Verdegaal,Anique L.C. Verpoorte,Monique K. van der Kooij,Linda de Bruin,Marten Visser,Caroline E. van der Minne,Vera Weeda,Inge C.F.M. Roozen,Mare A. Jonker,Inge M. Westra,Pauline Meij,Frank M. Speetjens,Stephanie M. Zunder,Gerrit‐Jan Liefers,Saskia J. Santegoets,Sjoerd H. van der Burg,Ellen Kapiteijn	2025	1
3	DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients Joosje C. Baltussen,Frederiek van den Bos,Marije Slingerland,T. Binda,Gerrit‐Jan Liefers,Wilbert B. van den Hout,Marta Fiocco,Arie J. Verschoor,Marissa Cloos‐van Balen,Cynthia Holterhues,Danny Houtsma,Anouk Jochems,Leontine E A M M Spierings,Leti van Bodegom‐Vos,Simon P. Mooijaart,Hans Gelderblom,Frank M. Speetjens,Nienke A. de Glas,Johanneke E. A. Portielje	2024	0
4	Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy Laura van ‘t Veer,Elma Meershoek‐Klein Kranenbarg,Marjolijn Duijm‐de Carpentier,Cornelis J. H. van de Velde,Miranda Kleijn,Christa Dreezen,Andrea Menicucci,William Audeh,Gerrit‐Jan Liefers	2024	1
5	Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery? M. Loo,Layla Andour,Anne E. van Heesewijk,Hendrika M. Oosterkamp,Gerrit‐Jan Liefers,Marieke E. Straver	2024	3
6	Physical Function and Physical Activity in Older Breast Cancer Survivors: 5-Year Follow-Up from the Climb Every Mountain Study Annelieke A. Lemij,Gerrit‐Jan Liefers,Marloes G.M. Derks,Esther Bastiaannet,Marta Fiocco,Titia E. Lans,Carmen C. van der Pol,Annelie J.E. Vulink,Leander van Gerven,Onno R. Guicherit,E. Linthorst-Niers,J. W. S. Merkus,Thijs van Dalen,Johanneke E.A. Portielje,Nienke A. de Glas	2023	10
7	Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study Joosje C. Baltussen,Marloes G.M. Derks,Annelieke A. Lemij,Nienke A. de Glas,Marta Fiocco,E. Linthorst-Niers,Annelie J.E. Vulink,Leander van Gerven,Onno R. Guicherit,Thijs van Dalen,J. W. S. Merkus,Titia E. Lans,Carmen C. van der Pol,Simon P. Mooijaart,Johanneke E.A. Portielje,Gerrit‐Jan Liefers	2023	3
8	Mental health outcomes in older breast cancer survivors: Five-year follow-up from the CLIMB study Annelieke A. Lemij,Nienke A. de Glas,Marloes G.M. Derks,E. Linthorst-Niers,Onno R. Guicherit,Carmen C. van der Pol,Titia E. Lans,Thijs van Dalen,Annelie J.E. Vulink,J. W. S. Merkus,Leander van Gerven,Frederiek van den Bos,Nathaly Rius Ottenheim,Gerrit‐Jan Liefers,Johanneke E.A. Portielje	2023	6
9	Time trends in treatment patterns and survival of older patients with synchronous metastatic colorectal cancer in the Netherlands: A population‐based study Joosje C. Baltussen,Nienke A. de Glas,Gerrit‐Jan Liefers,Marije Slingerland,Frank M. Speetjens,Frederiek van den Bos,Marissa Cloos‐van Balen,Arie J. Verschoor,Anouk Jochems,Leontine E.A.M.M. Spierings,Cynthia Holterhues,Leander A. van Gerven,Simon P. Mooijaart,Johanneke E.A. Portielje,Marloes G.M. Derks	2023	3
10	Breast cancer mortality of older patients with and without recurrence analysed by novel multi-state models Anna Z. de Boer,Esther Bastiaannet,Johannes Schetelig,Nienke A. de Glas,Damjan Manevksi,Hein Putter,Gerrit‐Jan Liefers,Linda de Munck,Johanneke E.A. Portielje,Liesbeth C. de Wreede	2022	4
11	Prediction of Other-Cause Mortality in Older Patients with Breast Cancer Using Comorbidity Anna Z. de Boer,Esther Bastiaannet,Hein Putter,Perla J. Marang‐van de Mheen,Sabine Siesling,Linda de Munck,Kelly M. de Ligt,Johanneke E.A. Portielje,Gerrit‐Jan Liefers,Nienke A. de Glas	2021	10
12	Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy Iris Noordhoek,Kai Treuner,Hein Putter,Yi Zhang,Jenna Wong,Elma Meershoek‐Klein Kranenbarg,Marjolijn Duijm‐de Carpentier,Cornelis J.�H. van de Velde,Catherine A. Schnabel,Gerrit‐Jan Liefers	2020	73
13	Oncologic treatment strategies and relative survival of patients with stage I–III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania A.J. Breugom,Esther Bastiaannet,Petra G. Boelens,E. Van Eycken,Lene Hjerrild Iversen,Anna Martling,Robert Johansson,T. Evans,Samuel Lawton,Katie M. O’Brien,Héctor Ortiz,Rasa Jančiauskienė,Olaf M. Dekkers,H.J.T. Rutten,Gerrit‐Jan Liefers,V.E.P.P. Lemmens,Cornelis J.�H. van de Velde	2018	8
14	The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer Martine A. Frouws,Eva Rademaker,Esther Bastiaannet,Myrthe P. P. van Herk‐Sukel,V.E.P.P. Lemmens,Cornelis J.�H. van de Velde,Johanneke E.A. Portielje,Gerrit‐Jan Liefers	2017	8
15	Adjuvant chemotherapy and relative survival of patients with stage II colon cancer – A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania A.J. Breugom,Esther Bastiaannet,Petra G. Boelens,Lene Hjerrild Iversen,Anna Martling,Robert Johansson,T. Evans,Samuel Lawton,K.M. O'Brien,E. Van Eycken,Rasa Jančiauskienė,Gerrit‐Jan Liefers,Andrés Cervantes,V.E.P.P. Lemmens,Cornelis J.�H. van de Velde	2016	20
16	Detection of breast cancer using near-infrared fluorescence imaging and methylene blue Quirijn R.J.G. Tummers,F.P.R. Verbeek,Boudewijn E. Schaafsma,Martin C. Boonstra,Joost R. van der Vorst,Gerrit‐Jan Liefers,Cornelis J.�H. van de Velde,J.V. Frangioni,Alexander L. Vahrmeijer	2013	1
17	Tumor stroma ratio as a predictor for response to neoadjuvant chemotherapy (TAC) in breast cancer (BC) : A Dutch Breast Cancer Trialists' Group (BOOG) side-study T.J.A. Dekker,Ayoub Charehbili,Vincent T.H.B.M. Smit,Elma Meershoek‐Klein Kranenbarg,R.A.E.M. Tollenaar,Cornelis J.�H. van de Velde,Gerrit‐Jan Liefers,J.W.R. Nortier,Wilma E. Mesker,Judith R. Kroep	2013	1
18	Clinical and pathological response after neoadjuvant chemotherapy with or without zoledronic acid for patients with HER2-negative large resectable or stage II or III breast cancer Ayoub Charehbili,Saskia van de Ven,Gerrit‐Jan Liefers,Vincent T.H.B.M. Smit,Martin N.J.M. Wasser,Elma Meershoek‐Klein Kranenbarg,A. Elise van Leeuwen‐Stok,Cornelis J.�H. van de Velde,J.W.R. Nortier,Judith R. Kroep	2013	1
19	Association Between Age at Diagnosis and Disease-Specific Mortality Among Postmenopausal Women With Hormone Receptor–Positive Breast Cancer W. van de Water,Christos Markopoulos,Cornelis J.�H. van de Velde,Caroline Seynaeve,Annette Hasenburg,Daniel Rea,Hein Putter,J.W.R. Nortier,Anton J.M. de Craen,E.T.M. Hille,Esther Bastiaannet,Peyman Hadji,Rudi G. J. Westendorp,Gerrit‐Jan Liefers,Stephen E. Jones	2012	21
20	Age-Specific Nonpersistence of Endocrine Therapy in Postmenopausal Patients Diagnosed with Hormone Receptor–Positive Breast Cancer: A TEAM Study Analysis W. van de Water,Esther Bastiaannet,E.T.M. Hille,Elma Meershoek‐Klein Kranenbarg,Hein Putter,Caroline Seynaeve,Robert Paridaens,Anton J. M. de Craen,Rudi G. J. Westendorp,Gerrit‐Jan Liefers,Cornelis J.�H. van de Velde	2011	40

About Gerrit‐Jan Liefers

Gerrit‐Jan Liefers is a scholar working on Cancer Research, Oncology and Geriatrics and Gerontology, having authored 243 papers that have together received 9.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (95 papers), Global Cancer Incidence and Screening (46 papers), Colorectal Cancer Surgical Treatments (32 papers), Genetic factors in colorectal cancer (32 papers), Colorectal Cancer Treatments and Studies (21 papers), Breast Lesions and Carcinomas (20 papers), Frailty in Older Adults (20 papers) and Estrogen and related hormone effects (18 papers). The work is most often cited by research in Oncology (5.2k citations), Cancer Research (2.8k citations) and Geriatrics and Gerontology (440 citations). Gerrit‐Jan Liefers has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Cornelis J.�H. van de Velde, Esther Bastiaannet, Hein Putter, Peter J.K. Kuppen, Rob A.�E.�M. Tollenaar, Vincent T.H.B.M. Smit, Johanneke E.A. Portielje, W. van de Water, Alexander L. Vahrmeijer and Anton J.M. de Craen.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact